Financial Survey: ReWalk Robotics (RWLK) versus Its Rivals

ReWalk Robotics (NASDAQ: RWLK) is one of 26 public companies in the “Surgical appliances & supplies” industry, but how does it contrast to its rivals? We will compare ReWalk Robotics to similar businesses based on the strength of its valuation, dividends, risk, profitability, institutional ownership, analyst recommendations and earnings.

Earnings & Valuation

How to Become a New Pot Stock Millionaire

This table compares ReWalk Robotics and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
ReWalk Robotics $7.75 million -$24.71 million -1.11
ReWalk Robotics Competitors $1.33 billion $194.17 million 23.46

ReWalk Robotics’ rivals have higher revenue and earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current recommendations for ReWalk Robotics and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReWalk Robotics 1 0 4 0 2.60
ReWalk Robotics Competitors 123 705 1254 53 2.58

ReWalk Robotics presently has a consensus target price of $2.80, indicating a potential upside of 154.52%. As a group, “Surgical appliances & supplies” companies have a potential upside of 0.27%. Given ReWalk Robotics’ stronger consensus rating and higher possible upside, analysts plainly believe ReWalk Robotics is more favorable than its rivals.

Insider & Institutional Ownership

2.5% of ReWalk Robotics shares are held by institutional investors. Comparatively, 54.5% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 6.9% of ReWalk Robotics shares are held by company insiders. Comparatively, 10.4% of shares of all “Surgical appliances & supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.


This table compares ReWalk Robotics and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ReWalk Robotics -318.81% -678.44% -85.08%
ReWalk Robotics Competitors -295.29% -52.73% -18.42%

Volatility & Risk

ReWalk Robotics has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, ReWalk Robotics’ rivals have a beta of 0.84, indicating that their average share price is 16% less volatile than the S&P 500.


ReWalk Robotics rivals beat ReWalk Robotics on 10 of the 13 factors compared.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with's FREE daily email newsletter.

Leave a Reply